Moderna Inc (NAS:MRNA)
$ 141.01 8.11 (6.1%) Market Cap: 54.04 Bil Enterprise Value: 43.65 Bil PE Ratio: 0 PB Ratio: 4.21 GF Score: 68/100

Moderna Inc at UBS Global Healthcare Conference (Virtual) Transcript

May 18, 2020 / 05:20PM GMT
Release Date Price: $80 (+19.96%)
Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic

Hello, and welcome to the UBS Healthcare Conference. This is day 1. Our next presentation and fireside chat is with Moderna.

My name is Navin Jacob. I'm senior analyst covering large-cap pharma and small-cap biotech here at UBS. I'm very happy to have with me today the Chief Medical Officer of Moderna ,Tal Zaks; as well as the Head of Investor Relations, Lavina Talukdar. Tal and Lavina, thank you so much for joining us today.

Tal Zaks
Moderna, Inc. - Chief Medical Officer

A pleasure to be here.

Lavina Talukdar
Moderna, Inc. - Head of IR

Thank you.

Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic

Fantastic. Well, a very eventful day for Moderna today and obviously, for the entire market as well. Very exciting news that you had to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot